Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1998 | 12-1997 | 12-1996 | 12-1995 | 12-1994 | |
| Sales | 9,236,800 | 8,517,600 | 7,346,600 | 6,763,800 | 5,711,600 |
| Cost of Goods | 2,015,100 | 2,362,900 | 2,118,400 | 1,885,700 | 1,679,700 |
| Gross Profit | 7,221,700 | 6,154,700 | 5,228,200 | 4,878,100 | 4,031,900 |
| Operating Expenses | 4,397,300 | 3,697,300 | 3,181,800 | 2,897,000 | 2,237,700 |
| Operating Income | 2,824,500 | 2,458,300 | 2,046,800 | 1,981,800 | 1,794,900 |
| Interest Expense | 181,300 | 234,100 | 288,800 | 286,300 | 103,800 |
| Other Income | 21,800 | -1,714,000 | 273,300 | 70,100 | 7,500 |
| Pre-tax Income | 2,665,000 | 510,200 | 2,031,300 | 1,765,600 | 1,698,600 |
| Income Tax | 568,700 | 895,300 | 507,800 | 459,000 | 513,500 |
| Net Income Continuous | 2,096,300 | 2,015,900 | 1,457,924 | 1,306,600 | 1,398,000 |
| Net Income Discontinuous | 1,600 | 0 | 0 | 984,300 | 0 |
| Net Income | $2,097,900 | $-385,100 | $1,523,500 | $2,290,900 | $1,286,100 |
| EPS Basic Total Ops | 1.91 | -0.35 | 1.39 | 2.02 | 1.11 |
| EPS Basic Continuous Ops | 1.91 | 1.83 | 1.33 | 1.15 | 1.21 |
| EPS Basic Discontinuous Ops | 0.00 | N/A | N/A | 0.86 | N/A |
| EPS Diluted Total Ops | 1.87 | -0.34 | 1.39 | 2.02 | 1.11 |
| EPS Diluted Continuous Ops | 1.91 | 1.78 | 1.33 | 1.15 | 1.21 |
| EPS Diluted Discontinuous Ops | 0.00 | N/A | N/A | 0.86 | N/A |
| EBITDA(a) | $3,314,900 | $2,968,100 | $2,590,300 | $2,535,500 | $2,227,100 |